Growth Metrics

Fulgent Genetics (FLGT) Change in Receivables (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Change in Receivables for 11 consecutive years, with $15.4 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables rose 15.4% to $15.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $23.3 million through Dec 2025, up 42.62% year-over-year, with the annual reading at $23.3 million for FY2025, 42.62% up from the prior year.
  • Change in Receivables hit $15.4 million in Q4 2025 for Fulgent Genetics, up from -$4.9 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $34.6 million in Q1 2021 to a low of -$67.1 million in Q2 2021.
  • Historically, Change in Receivables has averaged -$3.7 million across 5 years, with a median of $2.2 million in 2024.
  • Biggest YoY gain for Change in Receivables was 33364.42% in 2021; the steepest drop was 989.21% in 2021.
  • Year by year, Change in Receivables stood at $22.7 million in 2021, then plummeted by 295.67% to -$44.4 million in 2022, then soared by 111.72% to $5.2 million in 2023, then surged by 155.86% to $13.3 million in 2024, then rose by 15.4% to $15.4 million in 2025.
  • Business Quant data shows Change in Receivables for FLGT at $15.4 million in Q4 2025, -$4.9 million in Q3 2025, and $8.3 million in Q2 2025.